Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Daily 2% Chlorhexidine Gluconate Bathing on Central Line-Associated Bloodstream Infections in Critically Ill Children: A Single-Center Randomized Controlled Trial

NCT05995080 is registered in ClinicalTrials.gov with Istanbul Medeniyet University as lead sponsor.

NCT NCT05995080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05995080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Daily 2% Chlorhexidine Gluconate Bathing on Central Line-Associated Bloodstream Infections in Critically Ill Children: A Single-Center Randomized Controlled Trial
Lead sponsor
Istanbul Medeniyet University
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2023
Completion date
May 1, 2025
Enrollment
247 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bloodstream infection due to central venous catheter, central line-associated bloodstream infections